Hudie Wei

2.2k total citations · 2 hit papers
31 papers, 1.5k citations indexed

About

Hudie Wei is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Hudie Wei has authored 31 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 12 papers in Oncology and 5 papers in Immunology. Recurrent topics in Hudie Wei's work include Fibroblast Growth Factor Research (5 papers), RNA Interference and Gene Delivery (5 papers) and Cell death mechanisms and regulation (5 papers). Hudie Wei is often cited by papers focused on Fibroblast Growth Factor Research (5 papers), RNA Interference and Gene Delivery (5 papers) and Cell death mechanisms and regulation (5 papers). Hudie Wei collaborates with scholars based in China, United States and Germany. Hudie Wei's co-authors include Yongheng Chen, Haolan Wang, Ming Guo, Ming Guo, Longying Jiang, Shuyan Dai, Desheng Xiao, Lingzhi Qu, Huajun Zhang and Zhuchu Chen and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Hudie Wei

29 papers receiving 1.5k citations

Hit Papers

Targeting p53 pathways: mechanisms, structures and a... 2021 2026 2022 2024 2023 2021 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Targeting p53 pathways: mechanisms, structures and advances in therapy
    2023 486 citations Haolan Wang, Ming Guo et al. profile →
  2. Farnesoid X receptor (FXR): Structures and ligands
    2021 163 citations Longying Jiang, Huajun Zhang et al. Computational and Structural Biotechnology Journal profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hudie Wei China 14 835 550 220 211 166 31 1.5k
Lan Wang China 25 905 1.1× 274 0.5× 338 1.5× 367 1.7× 231 1.4× 74 1.8k
Lijun Di China 25 1.0k 1.3× 602 1.1× 389 1.8× 236 1.1× 163 1.0× 102 1.9k
Niklas K. Finnberg United States 18 678 0.8× 434 0.8× 234 1.1× 453 2.1× 240 1.4× 40 1.4k
Italia Falcone Italy 20 900 1.1× 508 0.9× 362 1.6× 203 1.0× 228 1.4× 39 1.6k
Stéphanie Solier France 17 1.9k 2.2× 669 1.2× 406 1.8× 161 0.8× 123 0.7× 33 2.3k
Zherui Wu China 18 749 0.9× 395 0.7× 365 1.7× 237 1.1× 165 1.0× 26 1.4k
Sheng-Chieh Hsu Taiwan 16 1.0k 1.2× 811 1.5× 364 1.7× 151 0.7× 86 0.5× 16 1.7k
Sven A. Lang Germany 24 928 1.1× 449 0.8× 298 1.4× 218 1.0× 95 0.6× 44 1.5k
Steven L. Wood United Kingdom 23 970 1.2× 431 0.8× 334 1.5× 142 0.7× 148 0.9× 35 1.8k
Ji Nie China 10 748 0.9× 327 0.6× 242 1.1× 92 0.4× 96 0.6× 12 1.3k

Countries citing papers authored by Hudie Wei

Since Specialization
Citations

This map shows the geographic impact of Hudie Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hudie Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hudie Wei more than expected).

Fields of papers citing papers by Hudie Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hudie Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hudie Wei. The network helps show where Hudie Wei may publish in the future.

Co-authorship network of co-authors of Hudie Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Hudie Wei. A scholar is included among the top collaborators of Hudie Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hudie Wei. Hudie Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lin, Hang, Lingzhi Qu, Hudie Wei, et al.. (2025). Characterization of Bozitinib as a potential therapeutic agent for MET-amplified gastric cancer. Communications Biology. 8(1). 134–134.
2.
Wei, Hudie, Haolan Wang, Jiaqi Wang, et al.. (2025). Deciphering molecular specificity in MCL-1/BAK interaction and its implications for designing potent MCL-1 inhibitors. Cell Death and Differentiation. 32(6). 991–999. 4 indexed citations
3.
Dai, Shuyan, et al.. (2024). Structural basis and selectivity of sulfatinib binding to FGFR and CSF-1R. Communications Chemistry. 7(1). 3–3. 6 indexed citations
4.
Jiang, Longying, Xujun Liang, Shuyan Dai, et al.. (2024). Structural characterization of the DNA binding mechanism of retinoic acid-related orphan receptor gamma. Structure. 32(4). 467–475.e3. 2 indexed citations
5.
Li, Hui‐Liang, Shuyan Dai, Lingzhi Qu, et al.. (2024). Design, synthesis, and biological evaluation of selective covalent inhibitors of FGFR4. European Journal of Medicinal Chemistry. 268. 116281–116281. 4 indexed citations
6.
Wei, Hudie, Haolan Wang, Lingzhi Qu, et al.. (2023). Structures of p53/BCL-2 complex suggest a mechanism for p53 to antagonize BCL-2 activity. Nature Communications. 14(1). 4300–4300. 58 indexed citations
7.
Qu, Lingzhi, Hang Lin, Shuyan Dai, et al.. (2023). Structural insight into the macrocyclic inhibitor TPX-0022 of c-Met and c-Src. Computational and Structural Biotechnology Journal. 21. 5712–5718. 5 indexed citations
8.
Qu, Lingzhi, Xiaojuan Chen, Hudie Wei, et al.. (2022). Structural insights into the potency and selectivity of covalent pan-FGFR inhibitors. Communications Chemistry. 5(1). 5–5. 17 indexed citations
9.
Jiang, Longying, Hudie Wei, Shuyan Dai, et al.. (2022). Structural insight into the molecular mechanism of cilofexor binding to the farnesoid X receptor. Biochemical and Biophysical Research Communications. 595. 1–6. 5 indexed citations
10.
Qu, Lingzhi, Ming Guo, Huajun Zhang, et al.. (2022). Characterization of the modification of Kelch-like ECH-associated protein 1 by different fumarates. Biochemical and Biophysical Research Communications. 605. 9–15. 7 indexed citations
11.
Dai, Shuyan, Lingzhi Qu, Jun Li, et al.. (2022). Structural insight into the ligand binding mechanism of aryl hydrocarbon receptor. Nature Communications. 13(1). 6234–6234. 37 indexed citations
12.
Guo, Ming, Shuyan Dai, ­Jun Li­, et al.. (2022). Structural study of ponatinib in inhibiting SRC kinase. Biochemical and Biophysical Research Communications. 598. 15–19. 10 indexed citations
13.
Chen, Xiaojuan, Hui‐Liang Li, Shuyan Dai, et al.. (2022). Structure-based design of a dual-warhead covalent inhibitor of FGFR4. Communications Chemistry. 5(1). 36–36. 13 indexed citations
14.
Wei, Hudie, Lingzhi Qu, Shuyan Dai, et al.. (2021). Structural insight into the molecular mechanism of p53-mediated mitochondrial apoptosis. Nature Communications. 12(1). 2280–2280. 76 indexed citations
15.
Wang, Haolan, Ming Guo, Hudie Wei, & Yongheng Chen. (2021). Targeting MCL-1 in cancer: current status and perspectives. Journal of Hematology & Oncology. 14(1). 67–67. 208 indexed citations
16.
Jiang, Longying, Huajun Zhang, Desheng Xiao, Hudie Wei, & Yongheng Chen. (2021). Farnesoid X receptor (FXR): Structures and ligands. Computational and Structural Biotechnology Journal. 19. 2148–2159. 163 indexed citations breakdown →
17.
Jiang, Longying, Desheng Xiao, Yubin Li, et al.. (2020). Structural basis of tropifexor as a potent and selective agonist of farnesoid X receptor. Biochemical and Biophysical Research Communications. 534. 1047–1052. 18 indexed citations
18.
Jiang, Longying, Shuyan Dai, Jun Li, et al.. (2019). Structural basis of binding of homodimers of the nuclear receptor NR4A2 to selective Nur-responsive DNA elements. Journal of Biological Chemistry. 294(51). 19795–19803. 25 indexed citations
19.
Jiang, Longying, Hudie Wei, Ningning Yan, et al.. (2019). Structural basis of NR4A1 bound to the human pituitary proopiomelanocortin gene promoter. Biochemical and Biophysical Research Communications. 523(1). 1–5. 7 indexed citations
20.
Wei, Hudie, Haiyan Cai, Jiawei Wu, et al.. (2016). Heparin Binds Lamprey Angiotensinogen and Promotes Thrombin Inhibition through a Template Mechanism. Journal of Biological Chemistry. 291(48). 24900–24911. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lan Wang Breakdown of academic impact, for papers by Lijun Di Breakdown of academic impact, for papers by Niklas K. Finnberg Breakdown of academic impact, for papers by Italia Falcone Breakdown of academic impact, for papers by Stéphanie Solier Breakdown of academic impact, for papers by Zherui Wu Breakdown of academic impact, for papers by Sheng-Chieh Hsu Breakdown of academic impact, for papers by Sven A. Lang Breakdown of academic impact, for papers by Steven L. Wood Breakdown of academic impact, for papers by Ji Nie
Rankless by CCL
2026